Cmejlova Jana, Dolezalova Ludmila, Pospisilova Dagmar, Petrtylova Kvetoslava, Petrak Jiri, Cmejla Radek
Department of Cell Physiology, Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20, Prague, Czech Republic.
Haematologica. 2006 Nov;91(11):1456-64.
Diamond-Blackfan anemia (DBA) is a rare congenital pure red cell aplasia characterized by normochromic macrocytic anemia, reticulocytopenia, and normocellular bone marrow with a selective deficiency of erythroid precursors. Ribosomal protein S19 (RPS19), currently the only gene associated with DBA, is mutated in 25% of DBA patients, but its role in erythropoiesis is unknown. We attempted to elucidate the importance of RPS19 in translation in relation to the pathogenesis of DBA.
We measured translation and proliferation rates in unstimulated and phytohemagglutinin (PHA)-stimulated lymphocytes isolated from DBA patients, as well as in K562 cells expressing several RPS19 mutants to directly test the effect of RPS19 mutations on translation. The effect of leucine on overall translation was also studied.
We found that the level of translation was on average 48-73% of controls in both unstimulated and PHA-activated DBA lymphocytes irrespective of mutations in RPS19. The addition of leucine increased the translational level in RPS19-non-mutated DBA cells, but not in cells with an RPS19 mutation. In unstimulated DBA cells, proliferation was significantly impaired in both RPS19-mutated and non-mutated cells, but in both groups could be efficiently activated by PHA. Studies on K562 cells showed that RPS19 mutations affecting RPS19 conserved arginines R56Q and R62Q could significantly inhibit the rate of protein synthesis, indicating the importance of RPS19 in translation.
Our results indicate that inefficient translation may be the main cause of DBA, and administration of leucine may be beneficial for at least some DBA patients.
先天性纯红细胞再生障碍性贫血(DBA)是一种罕见的先天性纯红细胞再生障碍,其特征为正色素性大细胞性贫血、网织红细胞减少,以及骨髓细胞正常但红系前体细胞选择性缺乏。核糖体蛋白S19(RPS19)是目前唯一与DBA相关的基因,25%的DBA患者存在该基因突变,但其在红细胞生成中的作用尚不清楚。我们试图阐明RPS19在翻译过程中的重要性及其与DBA发病机制的关系。
我们测定了从DBA患者分离出的未受刺激及经植物血凝素(PHA)刺激的淋巴细胞中的翻译和增殖速率,以及表达几种RPS19突变体的K562细胞中的翻译和增殖速率,以直接检测RPS19突变对翻译的影响。同时研究了亮氨酸对整体翻译的影响。
我们发现,无论RPS19是否发生突变,未受刺激及PHA激活的DBA淋巴细胞中的翻译水平平均为对照组的48%-73%。添加亮氨酸可提高RPS19未突变的DBA细胞的翻译水平,但对RPS19突变的细胞无效。在未受刺激的DBA细胞中,RPS19突变和未突变的细胞增殖均显著受损,但两组细胞均可被PHA有效激活。对K562细胞的研究表明,影响RPS19保守精氨酸R56Q和R62Q的RPS19突变可显著抑制蛋白质合成速率,表明RPS19在翻译过程中具有重要作用。
我们的结果表明,翻译效率低下可能是DBA的主要原因,补充亮氨酸可能对至少部分DBA患者有益。